SSRP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.499600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.985800E-01
Normal-vs-Stage2
9.796200E-01
Normal-vs-Stage3
3.261800E-01
Normal-vs-Stage4
5.664200E-01
Stage1-vs-Stage2
8.455600E-01
Stage1-vs-Stage3
2.673800E-01
Stage1-vs-Stage4
4.212800E-01
Stage2-vs-Stage3
1.660440E-01
Stage2-vs-Stage4
6.456400E-01
Stage3-vs-Stage4
1.790440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.751800E-01
Normal-vs-AfricanAmerican
8.065200E-01
Normal-vs-Asian
3.963400E-01
Caucasian-vs-AfricanAmerican
7.442200E-01
Caucasian-vs-Asian
2.002200E-01
AfricanAmerican-vs-Asian
1.955360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.253400E-01
Normal-vs-Female
9.797200E-01
Male-vs-Female
8.046000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.168800E-01
Normal-vs-Age(41-60Yrs)
6.865800E-01
Normal-vs-Age(61-80Yrs)
7.008000E-01
Normal-vs-Age(81-100Yrs)
6.632200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.739000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.952200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.294200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.700200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.706000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.233600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.444200E-01
Normal-vs-Daily Drinker
9.347400E-01
Normal-vs-Weekly Drinker
7.850200E-01
Normal-vs-Occasional Drinker
4.644400E-01
Normal-vs-Social Drinker
9.865800E-01
Non Drinker-vs-Daily Drinker
6.344600E-01
Non Drinker-vs-Weekly Drinker
9.992200E-01
Non Drinker-vs-Occasional Drinker
5.358100E-02
Non Drinker-vs-Social Drinker
5.370600E-01
Daily Drinker-vs-Weekly Drinker
7.154600E-01
Daily Drinker-vs-Occasional Drinker
1.868040E-01
Daily Drinker-vs-Social Drinker
8.615400E-01
Weekly Drinker-vs-Occasional Drinker
1.242830E-01
Weekly Drinker-vs-Social Drinker
6.306400E-01
Occasional Drinker-vs-Social Drinker
2.982600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.625000E-01
Normal-vs-Grade 2
9.489400E-01
Normal-vs-Grade 3
9.608400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.293940E-02
Grade 1-vs-Grade 3
3.157400E-04
Grade 1-vs-Grade 4
8.625000E-01
Grade 2-vs-Grade 3
1.397870E-02
Grade 2-vs-Grade 4
9.489400E-01
Grade 3-vs-Grade 4
9.608400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.794000E-01
Normal-vs-NonDiabetic
9.800800E-01
Diabetic-vs-NonDiabetic
3.181400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.533400E-01
Normal-vs-NoPancreatitis
8.970000E-01
Pancreatitis-vs-NoPancreatitis
4.496000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.774400E-01
Normal-vs-N1
9.308000E-01
N0-vs-N1
4.320800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.549000E-01
Normal-vs-TP53-NonMutant
7.561200E-01
TP53-Mutant-vs-TP53-NonMutant
5.92230000040495E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
